TINA MCKENNON: Open Payments
NPI 1992163422 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 10 payments from 7 companies in 2025. Trend: 2023 $384 · 2024 $1,043 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $172 |
| Amgen Inc. | 1 | $125 |
| Caris MPI, Inc. | 1 | $95 |
| BeOne Medicines USA, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: OPDIVO, IMDELLTRA (AMG757), MI CANCER SEEK, TEVIMBRA, Nubeqa, IMFINZI, DARZALEX.
Industry payments across PA — which companies pay providers there.
